EXOPHARM LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0275 AUD | +10.00% |
|
-.--% | -.--% |
| 26/02 | Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| 2023 | Exopharm to Cut CEO Role Amid Cost Reductions | MT |
Performance
| 1 day | +10.00% | ||
| 1 year | -42.11% | ||
| 3 years | -98.57% | ||
| 5 years | -97.41% |
Volumes
marketsDaily volume
29 049
Estimated daily volume
29 049
Record volume 1
8 321 108
Record volume 2
5 444 500
Record volume 3
4 294 944
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (AUD)
4 799 983
Capitalization (USD)
3 152 245
Net sales (AUD)
3 393 141
Net sales (USD)
2 228 344
Free-Float
24.71 %
Free-Float capitalization (AUD)
2 965 703
Free-Float capitalization (USD)
1 947 637
Highs and lows
1 year
0.01
0.04
3 years
0.011.94
5 years
0.012.50
10 years
0.012.50
Indicators
Moving average 5 days
0.01
Moving average 20 days
0.02
Moving average 50 days
0.02
Moving average 100 days
0.01
Price spread / (MMA5)
-62.18%
Price spread / (MMA20)
-13.09%
Price spread / (MMA50)
-12.00%
Price spread / (MMA100)
-64.73%
RSI 9 days
65.57
RSI 14 days
61.23
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +10.00% | -.--% | -.--% | -42.11% | 3.15M | ||
| +0.96% | +2.52% | +2.50% | +24.83% | 42.75B | ||
| -1.02% | +3.08% | +47.70% | -5.60% | 41.61B | ||
| +3.21% | +6.47% | +11.84% | -16.63% | 41.34B | ||
| +4.02% | +6.25% | -8.83% | +14.38% | 26.59B | ||
| -1.92% | +1.78% | +7.13% | +55.15% | 25.49B | ||
| +3.06% | +1.43% | -22.75% | -26.75% | 18.12B | ||
| +1.10% | +6.39% | +30.59% | +93.86% | 12.24B | ||
| +1.06% | -0.30% | -1.92% | +21.97% | 11.76B | ||
| +2.67% | +2.64% | +9.25% | +3.50% | 11B | ||
| +1.75% | +3.45% | -15.80% | -18.00% | 10.07B | ||
| +1.31% | +2.40% | -5.72% | -8.53% | 9.22B | ||
| +0.12% | +3.57% | +24.92% | -15.11% | 6.65B | ||
| +3.41% | +20.21% | +8.55% | -34.40% | 6.44B | ||
| +2.18% | +0.92% | +28.19% | +54.15% | 6.13B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | +1.98% | +3.39% | +7.71% | +6.71% | ||
| Weighted average by Cap. | +1.32% | +3.94% | +10.21% | +9.80% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2023 | -81.67% | ||
| 2022 | -88.46% | ||
| 2021 | -8.77% | ||
| 2020 | +119.23% | ||
| 2019 | -52.73% | ||
| 2018 | +5.77% |
- Stock Market
- Equities
- EX1 Stock
- Quotes Exopharm Limited
